These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32703725)

  • 21. The BioVisualSpeech Serious Game with Voice Exercises for People with Parkinson's Disease with Hypokinetic Dysarthria.
    Viana T; Cavaco S
    Stud Health Technol Inform; 2022 Jun; 290():919-923. PubMed ID: 35673153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptual Judgment of Voice Quality in Nondysphonic French Speakers: Effect of Task-, Speaker- and Listener-Related Variables.
    Delvaux V; Pillot-Loiseau C
    J Voice; 2020 Sep; 34(5):682-693. PubMed ID: 30922738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Acoustic Perceptual Relationship of Speech in Parkinson's Disease.
    Chiu YF; Neel A; Loux T
    J Speech Lang Hear Res; 2021 May; 64(5):1560-1570. PubMed ID: 33900806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auditory-perceptual voice and speech evaluation in ATP1A3 positive patients.
    Moya-Mendez ME; Madden LL; Ruckart KW; Downes KM; Cook JF; Snively BM; Brashear A; Haq IU
    J Clin Neurosci; 2020 Nov; 81():133-138. PubMed ID: 33222902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysarthria treatment for Parkinson's disease: one-year follow-up of SPEAK OUT!
    Behrman A; Cody J; Chitnis S; Elandary S
    Logoped Phoniatr Vocol; 2022 Dec; 47(4):271-278. PubMed ID: 34338571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Acoustic Voice Quality Index in the Lithuanian Language.
    Uloza V; Petrauskas T; Padervinskis E; Ulozaitė N; Barsties B; Maryn Y
    J Voice; 2017 Mar; 31(2):257.e1-257.e11. PubMed ID: 27427182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
    Alharbi GG; Cannito MP; Buder EH; Awan SN
    Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of Occupation on Self-perceived Vocal Problems in Patients With Voice Complaints.
    Ebersole B; Soni RS; Moran K; Lango M; Devarajan K; Jamal N
    J Voice; 2018 Nov; 32(6):673-680. PubMed ID: 28967587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a large scale population screening tool for the assessment of Parkinson's disease using telephone-quality voice.
    Arora S; Baghai-Ravary L; Tsanas A
    J Acoust Soc Am; 2019 May; 145(5):2871. PubMed ID: 31153319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis.
    Muñoz-Vigueras N; Prados-Román E; Valenza MC; Granados-Santiago M; Cabrera-Martos I; Rodríguez-Torres J; Torres-Sánchez I
    Clin Rehabil; 2021 May; 35(5):639-655. PubMed ID: 33233932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates.
    Cannito MP; Doiuchi M; Murry T; Woodson GE
    J Voice; 2012 Nov; 26(6):818.e5-13. PubMed ID: 23177751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) Psychometric Characteristics: II European Portuguese Version (II EP CAPE-V).
    de Almeida SC; Mendes AP; Kempster GB
    J Voice; 2019 Jul; 33(4):582.e5-582.e13. PubMed ID: 29936062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of the Dysphonia Severity Index (DSI), Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V), and Gender in Brazilians With and Without Voice Disorders.
    Nemr K; Simões-Zenari M; de Souza GS; Hachiya A; Tsuji DH
    J Voice; 2016 Nov; 30(6):765.e7-765.e11. PubMed ID: 26627119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory Perception of Roughness and Breathiness by Dysphonic Women.
    Paz KEDS; de Almeida AAF; Almeida LNA; Sousa ESDS; Lopes LW
    J Voice; 2024 Sep; 38(5):1249.e1-1249.e18. PubMed ID: 35082050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.